Increased osteoprotegerin serum levels in men with coronary artery disease

被引:283
|
作者
Schoppet, M
Sattler, AM
Schaefer, JR
Herzum, M
Maisch, B
Hofbauer, LC
机构
[1] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, Dept Med, D-35033 Marburg, Germany
[2] Univ Marburg, Dept Internal Med, D-35033 Marburg, Germany
[3] Univ Marburg, Dept Cardiol, D-35033 Marburg, Germany
来源
关键词
D O I
10.1210/jc.2002-020775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
osteoprotegerin (OPG) regulates osteoclast and immune functions and appears to represent a protective factor for the vascular system. However, the role of OPG in human atherosclerosis has not been evaluated. In this study, we assessed OPG serum levels in 522 age-matched men who, on the basis of coronary angiography, had either absence of coronary artery disease (CAD) or presence of single-vessel disease, double-vessel disease, or severe triple-vessel disease. OPG serum levels were positively correlated with age (r = 0.28; P < 0.001) and were higher in men with diabetes mellitus (P < 0.01). OPG serum levels in men without CAD were 5.4 +/- 2.0 pmol/liter, compared with 6.1 +/- 2.1 pmol/liter in single-vessel disease (P < 0.005), 5.9 +/- 2.4 in double-vessel disease (P < 0.05), and 6.3 +/- 2.3 pmol/liter in triple-vessel disease (P < 0.001). Moreover, OPG serum levels were positively correlated with the severity of CAD as determined by a CAD scoring system (r = 0.17; P < 0.01). In conclusion, our data underline that OPG serum levels are associated with the severity of CAD and are increased in elderly men and patients with diabetes mellitus. We conclude that increased OPG serum levels may reflect advanced cardiovascular disease in men.
引用
收藏
页码:1024 / 1028
页数:5
相关论文
共 50 条
  • [1] Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
    Jono, S
    Ikari, Y
    Shioi, A
    Mori, K
    Miki, T
    Hara, K
    Nishizawa, Y
    [J]. CIRCULATION, 2002, 106 (10) : 1192 - 1194
  • [2] Osteoprotegerin gene polymorphisms in men with coronary artery disease
    Soufi, M
    Schoppet, M
    Sattler, AM
    Herzum, M
    Maisch, B
    Hofbauer, LC
    Schaefer, JR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3764 - 3768
  • [3] Increased serum levels of fetuin B in patients with coronary artery disease
    Kefu Zhu
    Yuming Wang
    Pengqin Shu
    Qinyi Zhou
    Jinzhou Zhu
    Wenjing Zhou
    Changqing Du
    Chenkai Xu
    Xiaowei Liu
    Lijiang Tang
    [J]. Endocrine, 2017, 58 : 97 - 105
  • [4] Increased serum levels of fetuin B in patients with coronary artery disease
    Zhu, Kefu
    Wang, Yuming
    Shu, Pengqin
    Zhou, Qinyi
    Zhu, Jinzhou
    Zhou, Wenjing
    Du, Changqing
    Xu, Chenkai
    Liu, Xiaowei
    Tang, Lijiang
    [J]. ENDOCRINE, 2017, 58 (01) : 97 - 105
  • [5] SERUM OSTEOPROTEGERIN LEVELS AND LONG-TERM PROGNOSIS IN SUBJECTS WITH STABLE CORONARY ARTERY DISEASE
    Otsuki, Shuji
    Jono, Shuichi
    Higashikuni, Yasutomi
    Shioi, Atsushi
    Mori, Katsuhito
    Tanabe, Kengo
    Nakajima, Hiroyoshi
    Hara, Kazuhiro
    Nishizawa, Yoshiki
    Ikari, Yuji
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [6] Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients
    Maniatis, Konstantinos
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Vavuranakis, Manolis
    Zaromytidou, Marina
    Mourouzis, Konstantinos
    Paraskevopoulos, Thodoros
    Charalambous, Georgios
    Papavassiliou, Athanasios G.
    Tousoulis, Dimitris
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 523 - 530
  • [7] Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
    Tousoulis, Dimitris
    Siasos, Gerasimos
    Maniatis, Konstantinos
    Oikonomou, Evangelos
    Kioufis, Stamatios
    Zaromitidou, Marina
    Paraskevopoulos, Thodoris
    Michalea, Stavroula
    Kollia, Christina
    Miliou, Antigoni
    Kokkou, Eleni
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1924 - 1928
  • [8] OSTEOPROTEGERIN AND OSTEOPONTIN SERUM LEVELS ARE ASSOCIATED WITH VASCULAR FUNCTION IN CORONARY ARTERY DISEASE: THE ROLE OF INFLAMMATION
    Maniatis, Konstantinos
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Kioufis, Stamatios
    Miliou, Antigoni
    Kokkou, Eleni
    Papageorgiou, Nikolaos
    Vavuranakis, Manolis
    Tsouroulas, Stamatios
    Gouliopoulos, Nikolaos
    Papavassiliou, Athanasios
    Stefanadis, Christodoulos I.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1187 - E1187
  • [9] Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
    Jono, S.
    Otsuki, S.
    Higashikuni, Y.
    Shioi, A.
    Mori, K.
    Hara, K.
    Hashimoto, H.
    Ikari, Y.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1170 - 1175
  • [10] Osteoprotegerin and osteopontin serum levels are associated with vascular function and inflammatory process in coronary artery disease
    Maniatis, K.
    Siasos, G.
    Tousoulis, D.
    Oikonomou, E.
    Zaromitidou, M.
    Kioufis, S.
    Kokkou, E.
    Gouliopoulos, N.
    Mazaris, S.
    Stefanadis, C.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 116 - 117